Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
220 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00430781 | Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer | completed | Phase 2 | 228 | GlaxoSmithKlineINDUSTRY | 13 | May 8, 2015 | clinicaltrials |
| NCT00943553 | A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects | withdrawn | Phase 2 | 0 | Eisai Inc.INDUSTRY | 1 | Apr 13, 2015 |
| clinicaltrials |
| NCT00300950 | Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer | completed | Phase 2 | 176 | GlobeImmuneINDUSTRY | 2 | Apr 6, 2015 | clinicaltrials |
| NCT02350855 | Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients | completed | Phase 2 | 62 | University of WestminsterOTHER | 2 | Jan 30, 2015 | clinicaltrials |
| NCT01955824 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | completed | Phase 2 / Phase 3 | 500 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT00911859 | A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients | completed | Phase 2 | 118 | Janssen Research & Development, LLCINDUSTRY | 11 | Nov 18, 2014 | clinicaltrials |
| NCT02240771 | Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | 124 | All India Institute of Medical SciencesOTHER | 1 | Sep 16, 2014 | clinicaltrials |
| NCT00532259 | CT-011 MAb in DLBCL Patients Following ASCT | completed | Phase 2 | 72 | CureTech LtdINDUSTRY | 3 | Sep 12, 2014 | clinicaltrials |
| NCT01238107 | A Clinical Study With MT-102 in Subjects With Cancer Cachexia | completed | Phase 2 | 87 | Akamis BioINDUSTRY | 3 | Sep 10, 2014 | clinicaltrials |
| NCT01903018 | A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 | completed | Phase 2 | 73 | Piramal Enterprises LimitedINDUSTRY | 1 | Sep 4, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT02103322 | Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions | completed | Phase 2 / Phase 3 | 48 | Amneal Pharmaceuticals, LLCINDUSTRY | 1 | Jun 27, 2014 | clinicaltrials |
| NCT00128362 | Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer | terminated | Phase 2 | 478 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00507429 | Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer(FACT) | terminated | Phase 2 / Phase 3 | 80 | Mateon TherapeuticsINDUSTRY | 12 | Jun 9, 2014 | clinicaltrials |
| NCT00677716 | Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse | completed | Phase 2 | 41 | Peregrine PharmaceuticalsINDUSTRY | 2 | Apr 24, 2014 | clinicaltrials |
| NCT00786838 | A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | completed | Phase 2 | 76 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 7 | Apr 11, 2014 | clinicaltrials |
| NCT00431561 | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma | completed | Phase 2 | 141 | Isarna Therapeutics GmbHINDUSTRY | 6 | Dec 3, 2013 | clinicaltrials |
| NCT00389441 | Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | completed | Phase 2 | 52 | PfizerINDUSTRY | 9 | Nov 25, 2013 | clinicaltrials |
| NCT01950611 | Proteasome Inhibition in Acute Promyelocytic Leukemia(PIAPL) | unknown | Phase 2 | 30 | Christian Medical College, Vellore, IndiaOTHER | 1 | Sep 25, 2013 | clinicaltrials |
| NCT00632047 | Early Detection of Breast Cancer and Cervical Cancer in Women in India | unknown | Phase 2 | 151,538 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00315757 | Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 105 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT01387841 | Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting | completed | Phase 2 | 120 | Bharath Charitable Cancer Hospital and InstituteOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT00391183 | Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. | completed | Phase 2 / Phase 3 | 60 | All India Institute of Medical SciencesOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00824343 | A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer(MONARCH) | completed | Phase 2 | 86 | Piramal Enterprises LimitedINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01337154 | First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 140 | CytRxINDUSTRY | 6 | Jun 28, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
| NCT00537381 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | completed | Phase 2 | 131 | Centocor, Inc.INDUSTRY | 10 | Jun 20, 2013 | clinicaltrials |
| NCT00077857 | A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 470 | Hoffmann-La RocheINDUSTRY | 9 | May 10, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00527319 | Regimen for the Treatment of Cachexia in Subjects With NSCLC(VT-122) | completed | Phase 2 | 37 | Vicus TherapeuticsINDUSTRY | 2 | Jan 30, 2013 | clinicaltrials |
| NCT00327444 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 / Phase 3 | 58 | SanofiINDUSTRY | 9 | Jan 1, 2013 | clinicaltrials |
| NCT00835419 | Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression(ENVER) | completed | Phase 2 | 12 | Piramal Enterprises LimitedINDUSTRY | 3 | Dec 4, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT00899054 | Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer(SPARK) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 22, 2012 | clinicaltrials |
| NCT00882063 | Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 19 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 21, 2012 | clinicaltrials |
| NCT00793546 | Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer | terminated | Phase 2 | 42 | PfizerINDUSTRY | 11 | Nov 5, 2012 | clinicaltrials |
| NCT01190982 | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer | completed | Phase 2 | 70 | INSYS Therapeutics IncINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 221 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00843050 | A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma | terminated | Phase 2 | 13 | Piramal Enterprises LimitedINDUSTRY | 2 | Jul 27, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 174 | PfizerINDUSTRY | 8 | Jun 26, 2012 | clinicaltrials |
| NCT00525408 | A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer(HRPC) | terminated | Phase 2 | 134 | Cadila PharnmaceuticalsINDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00018954 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 3 | Feb 20, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00448305 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | completed | Phase 2 | 143 | MediGeneINDUSTRY | 6 | Jan 5, 2012 | clinicaltrials |
| NCT01429766 | A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients | unknown | Phase 2 | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00630110 | Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 172 | Nereus Pharmaceuticals, Inc.INDUSTRY | 6 | Aug 16, 2011 | clinicaltrials |
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma(dtZ) | completed | Phase 2 | 56 | Gleneagles HospitalOTHER | 3 | Jul 21, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials